Schmid Timothy (CIK 1998491) reported 19 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-04). Recent activity: Buy JNJ (11,070 shares), Sell JNJ (11,070 shares), Buy JNJ (22,527 shares), Sell JNJ (22,527 shares), Sell JNJ (1,322 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-04 | JOHNSON & JOHNSON (JNJ) | EVP, WW Chair, MedTech | Buy | 11,070 | $1.5M |
| 2026-09-04 | JOHNSON & JOHNSON (JNJ) | EVP, WW Chair, MedTech | Sell | 11,070 | $3.0M |
| 2026-09-04 | JOHNSON & JOHNSON (JNJ) | EVP, WW Chair, MedTech | Buy | 22,527 | $3.4M |
| 2026-09-04 | JOHNSON & JOHNSON (JNJ) | EVP, WW Chair, MedTech | Sell | 22,527 | $6.2M |
| 2026-02-23 | JOHNSON & JOHNSON (JNJ) | EVP, WW Chair, MedTech | Sell | 1,322 | $324,763 |
| 2026-02-18 | JOHNSON & JOHNSON (JNJ) | EVP, WW Chair, MedTech | Buy | 499 | $0 |
| 2026-02-18 | JOHNSON & JOHNSON (JNJ) | EVP, WW Chair, MedTech | Sell | 8 | $1,956 |
| 2026-02-18 | JOHNSON & JOHNSON (JNJ) | EVP, WW Chair, MedTech | Buy | 4,378 | $0 |
| 2026-02-18 | JOHNSON & JOHNSON (JNJ) | EVP, WW Chair, MedTech | Sell | 1,816 | $444,103 |
| 2026-02-18 | JOHNSON & JOHNSON (JNJ) | EVP, WW Chair, MedTech | Buy | 1,028 | $0 |
| 2026-02-18 | JOHNSON & JOHNSON (JNJ) | EVP, WW Chair, MedTech | Sell | 15 | $3,652 |
| 2026-02-18 | JOHNSON & JOHNSON (JNJ) | EVP, WW Chair, MedTech | Buy | 1,026 | $0 |
| 2026-02-18 | JOHNSON & JOHNSON (JNJ) | EVP, WW Chair, MedTech | Sell | 448 | $109,066 |
| 2026-02-18 | JOHNSON & JOHNSON (JNJ) | EVP, WW Chair, MedTech | Buy | 13,625 | $1.6M |
| 2026-02-18 | JOHNSON & JOHNSON (JNJ) | EVP, WW Chair, MedTech | Sell | 13,625 | $3.3M |
| 2026-02-18 | JOHNSON & JOHNSON (JNJ) | EVP, WW Chair, MedTech | Buy | 8,998 | $1.2M |
| 2026-02-18 | JOHNSON & JOHNSON (JNJ) | EVP, WW Chair, MedTech | Sell | 8,998 | $2.2M |
| 2026-02-10 | JOHNSON & JOHNSON (JNJ) | EVP, WW Chair, MedTech | Buy | 15,571 | $1.6M |
| 2026-02-10 | JOHNSON & JOHNSON (JNJ) | EVP, WW Chair, MedTech | Sell | 10,335 | $2.5M |
来源：SEC Form 4 申报文件 · 截至 2026-09-04